High-performance liquid chromatographic assay of dilazep in plasma after solid-phase extraction.
A new, simple and accurate high-performance liquid chromatography method is presented for measuring dilazep in plasma, using a reversed-phase technique and UV absorption at 267 nm. Dilazep and papaverine (the internal standard) added to plasma were successfully isolated using a solid-phase extraction procedure (CN cartridges). The method was linear between 2.5-12.5 micrograms ml-1. Over the tested concentration range the intra-day coefficient of variation for replicate analyses of plasma ranged from 2.38 to 5.27% (the day-to-day CV ranged from 2.52 to 7.99%). The detection limit for the analysis of dilazep in plasma was 50 ng with 20 microliters injection.
Gumieniczek
A
A
Department of Medicinal Chemistry, Medical Academy, Lublin, Poland.
Przyborowski
L
L
D002851:Chromatography, High Pressure Liquid; D004109:Dilazep / Q000097:blood*; D006801:Humans; D015203:Reproducibility of Results; D013056:Spectrophotometry, Ultraviolet; D014665:Vasodilator Agents / Q000097:blood*
D014665:Vasodilator Agents; D004109:Dilazep